Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 05/17/2019
Closing price: 169.91
| Support price level: | N/A |
| Resistance price level: | $179.44 |
| Relative strength index (14-day RSI) | 21.4 |
| Beta | 1.09 |
- AMGN is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- Volatility is forecast to fall over the next month.
- With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
| Low | High | Price as % of Range |
| $167.60 | $208.89 | 6.2% |
| 200 day | 50 day | 20 day | 10 day |
| $192.45 | $183.52 | $174.99 | $171.29 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 24.0% | 27.8% | 24.1% | 23.8% |
- 6.6% in the next week.
- 13.5% in the next month.
- 42.0% in the next year.
